BEGIN:VCALENDAR VERSION:2.0 PRODID:-//141.193.213.21//NONSGML kigkonsult.se iCalcreator 2.20// CALSCALE:GREGORIAN METHOD:PUBLISH X-FROM-URL:https://alleviate-ad.com X-WR-TIMEZONE:Atlantic/Azores BEGIN:VTIMEZONE TZID:Atlantic/Azores X-LIC-LOCATION:Atlantic/Azores BEGIN:STANDARD DTSTART:20231029T010000 TZOFFSETFROM:+0000 TZOFFSETTO:-0100 RDATE:20241027T010000 TZNAME:-01 END:STANDARD BEGIN:DAYLIGHT DTSTART:20240331T000000 TZOFFSETFROM:-0100 TZOFFSETTO:+0000 TZNAME:+00 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT UID:ai1ec-207756@alleviate-ad.com DTSTAMP:20240329T160223Z CATEGORIES;LANGUAGE=en-US:Online Programs CONTACT: DESCRIPTION:Atopic Dermatitis \n \n \n \n \n Home\nAbout Us\nClinical Toolkit\n\n Clinical Toolkit Home\n Diagnosis\n Management and Techniques\n Treatment\n Ad ditional Reading\n\n\nPatient Toolkit\n\n Patient Toolkit Home\n Living With Eczema\n FAQ\n Resources\n Let’s Talk!\n\n\nCME Activities\nHD Visual Learni ng\nVR Learning Lab\nFree Poster\nContact\n \n \n Menu\n \n \n Home\nAbout Us\nC linical Toolkit\n\n Clinical Toolkit Home\n Diagnosis\n Management and Techni ques\n Treatment\n Additional Reading\n\n\nPatient Toolkit\n\n Patient Toolki t Home\n Living With Eczema\n FAQ\n Resources\n Let’s Talk!\n\n\nCME Activitie s\nHD Visual Learning\nVR Learning Lab\nFree Poster\nContact\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Atopic Dermatitis: Where Are We? \n \n \n \n Atopic dermatitis (AD)\, also known as e czema\, is one of the most common inflammatory skin disorders worldwide\, with an increasing incidence in the last few decades\, especially in devel oped countries. In recent years\, we’ve started to figure out some of the underlying causes of atopic dermatitis\, which has led to the development of new targeted therapies and improved treatment methods for this challeng ing disease.Thank you for visiting us today. We welcome you to our website and invite you to explore the links beside for information on AD for clin icians and patients.Enjoy! \n \n \n \n \n \n \n \n \n \n Clinical Toolkit\n Patient To olkit\n \n \n Clinical Toolkit\n Clinical ToolkitDiagnosisManagement and Techn iquesTreatmentAdditional Reading\n Patient Toolkit\n Patient ToolkitLiving W ith EczemaFAQResourcesLet’s Talk!\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n T his activity is provided by Med Learning Group. This activity is co-provid ed by Ultimate Medical Academy/Complete Conference Management (CCM).This a ctivity is supported by an educational grant from Lilly. \n \n \n \n Copyright © 2019jQuery(function($){$('.divibooster_year').text(new Date().getFullYea r())\;})\; Med Learning Group. Built by Divigner. All Rights Reserved. DTSTART;TZID=Atlantic/Azores:20210408T070000 DTEND;TZID=Atlantic/Azores:20220408T080000 SEQUENCE:0 SUMMARY:Below the Surface: Managing the Physical\, Mental\, and Social Impa ct of Moderate-to-Severe Atopic Dermatitis URL:https://alleviate-ad.com/event/below-the-surface-managing-the-physical- mental-and-social-impact-of-moderate-to-severe-atopic-dermatitis-7/ X-COST-TYPE:free X-WP-IMAGES-URL:thumbnail\;https://alleviate-ad.com/wp-content/uploads/2020 /12/Alleviate-Logo-v2-1.gif\;560\;342\,medium\;https://alleviate-ad.com/wp -content/uploads/2020/12/Alleviate-Logo-v2-1.gif\;560\;342\,large\;https:/ /alleviate-ad.com/wp-content/uploads/2020/12/Alleviate-Logo-v2-1.gif\;560\ ;342\,full\;https://alleviate-ad.com/wp-content/uploads/2020/12/Alleviate- Logo-v2-1.gif\;560\;342 X-ALT-DESC;FMTTYPE=text/html:\\n\\n
\\n